Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Approves First Drug for Advanced Macular Degeneration

Teprotumumab reduces inflammation, which causes damage in the eye that leads to progressive central vision loss.

Goggles
Getty Images

Macular degeneration is caused by the deterioration of the macula, a small part of the retina that is responsible for sharp, central vision. It’s most common in older adults and can lead to severe vision loss or blindness. According to a recent CBS News article, the FDA has approved the first and only drug for the treatment of advanced macular degeneration. The drug, teprotumumab, is administered intravenously and has proven effective in clinical trials, with some patients experiencing significant improvement in vision.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences